Search research articles
Contact Us
Filters
Showing results (351-360 of 386) with videos related to
Page
of 39
Sort By:
Science (New York, N.Y.)
|
January 8, 2021
Structural basis for antibody inhibition of flavivirus NS1-triggered endothelial dysfunction
Scott B Biering, David L Akey, Marcus P Wong, et al.
The Lancet. Oncology
|
August 2, 2021
Ipilimumab versus ipilimumab plus anti-PD-1 for metastatic melanoma - Authors' reply
Ines Pires da Silva, Tasnia Ahmed, Irene L M Reijers, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 5, 2024
Predicting Recurrence-Free and Overall Survival for Patients With Stage II Melanoma: The MIA Calculator
Alexander H R Varey, Isabel Li, Mary-Ann El Sharouni, et al.
Annals of Surgical Oncology
|
November 15, 2023
Role of Concurrent Ultrasound Surveillance of Sentinel Node-Positive Node Fields in Melanoma Patients Having Routine Cross-Sectional Imaging
Caroline A Gjorup, Rachel Woodford, Isabel Li, et al.
International Journal of Cancer
|
September 28, 2020
Prognostic significance of postsurgery circulating tumor DNA in nonmetastatic colorectal cancer: Individual patient pooled analysis of three cohort studies
Jeanne Tie, Joshua D Cohen, Serigne N Lo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 26, 2019
Adjuvant Whole-Brain Radiation Therapy Compared With Observation After Local Treatment of Melanoma Brain Metastases: A Multicenter, Randomized Phase III Trial
Angela M Hong, Gerald B Fogarty, Kari Dolven-Jacobsen, et al.
Nature Medicine
|
March 7, 2025
Circulating tumor DNA analysis guiding adjuvant therapy in stage II colon cancer: 5-year outcomes of the randomized DYNAMIC trial
Jeanne Tie, Yuxuan Wang, Serigne N Lo, et al.
The New England Journal of Medicine
|
June 3, 2022
Circulating Tumor DNA Analysis Guiding Adjuvant Therapy in Stage II Colon Cancer
Jeanne Tie, Joshua D Cohen, Kamel Lahouel, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 12, 2024
Outcomes following long-term disease control with immune checkpoint inhibitors in patients with advanced melanoma
Eleanor E Handel, Janet McKeown, Joe Wei, et al.
Biorxiv : the Preprint Server for Biology
|
December 21, 2021
SARS-CoV-2 Spike triggers barrier dysfunction and vascular leak via integrins and TGF-β signaling
Scott B Biering, Francielle Tramontini Gomes de Sousa, Laurentia V Tjang, et al.
Page
of 39
Search research articles
Search
Showing results (351-360 of 386) with videos related to
Sort By:
Page
of 39
Science (New York, N.Y.)
|
January 8, 2021
Structural basis for antibody inhibition of flavivirus NS1-triggered endothelial dysfunction
Scott B Biering, David L Akey, Marcus P Wong, et al.
The Lancet. Oncology
|
August 2, 2021
Ipilimumab versus ipilimumab plus anti-PD-1 for metastatic melanoma - Authors' reply
Ines Pires da Silva, Tasnia Ahmed, Irene L M Reijers, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 5, 2024
Predicting Recurrence-Free and Overall Survival for Patients With Stage II Melanoma: The MIA Calculator
Alexander H R Varey, Isabel Li, Mary-Ann El Sharouni, et al.
Annals of Surgical Oncology
|
November 15, 2023
Role of Concurrent Ultrasound Surveillance of Sentinel Node-Positive Node Fields in Melanoma Patients Having Routine Cross-Sectional Imaging
Caroline A Gjorup, Rachel Woodford, Isabel Li, et al.
International Journal of Cancer
|
September 28, 2020
Prognostic significance of postsurgery circulating tumor DNA in nonmetastatic colorectal cancer: Individual patient pooled analysis of three cohort studies
Jeanne Tie, Joshua D Cohen, Serigne N Lo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 26, 2019
Adjuvant Whole-Brain Radiation Therapy Compared With Observation After Local Treatment of Melanoma Brain Metastases: A Multicenter, Randomized Phase III Trial
Angela M Hong, Gerald B Fogarty, Kari Dolven-Jacobsen, et al.
Nature Medicine
|
March 7, 2025
Circulating tumor DNA analysis guiding adjuvant therapy in stage II colon cancer: 5-year outcomes of the randomized DYNAMIC trial
Jeanne Tie, Yuxuan Wang, Serigne N Lo, et al.
The New England Journal of Medicine
|
June 3, 2022
Circulating Tumor DNA Analysis Guiding Adjuvant Therapy in Stage II Colon Cancer
Jeanne Tie, Joshua D Cohen, Kamel Lahouel, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 12, 2024
Outcomes following long-term disease control with immune checkpoint inhibitors in patients with advanced melanoma
Eleanor E Handel, Janet McKeown, Joe Wei, et al.
Biorxiv : the Preprint Server for Biology
|
December 21, 2021
SARS-CoV-2 Spike triggers barrier dysfunction and vascular leak via integrins and TGF-β signaling
Scott B Biering, Francielle Tramontini Gomes de Sousa, Laurentia V Tjang, et al.
Page
of 39